| PRD_000382 | Name: | N-[(1R,2R,4R)-1-(cyclohexylmethyl)-2-hydroxy-6-methyl-4-{[(2R)-2-methylbutyl]carbamoyl}heptyl]-3-(1H-imidazol-3-ium-4-y
l)-N~2~-[3-naphthalen-1-yl-2-(naphthalen-1-ylmethyl)propanoyl]-L-alaninamide | Formula: | C51 H68 N5 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000383 | Name: | N-{(3S)-3-[(tert-butoxycarbonyl)amino]-4-phenylbutyl}-L-phenylalanyl-L-alpha-glutamyl-L-phenylalaninamide | Formula: | C38 H49 N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000384 | Name: | N-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-4-phenylbutyl}-L-phenylalanyl-L-glutaminyl-L-phenylalaninamide | Formula: | C38 H50 N6 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000385 | Name: | N-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-4-phenylbutyl}-L-phenylalanyl-L-alpha-glutamyl-L-phenylalaninamide | Formula: | C38 H49 N5 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000386 | Name: | N-{(2S,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-4-phenylbutyl}-L-phenylalanyl-L-alpha-glutamyl-L-phenylalaninamide | Formula: | C38 H49 N5 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000388 | Name: | N-(tert-butoxycarbonyl)-L-alanyl-N-{(1S)-5-ammonio-1-[hydroxy(3-hydroxypropoxy)boranyl]pentyl}-L-valinamide | Formula: | C21 H44 B N4 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000389 | Name: | N-(tert-butoxycarbonyl)-L-alanyl-N-[(1S)-5-amino-1-(diethoxyboranyl)pentyl]-L-valinamide | Formula: | C22 H45 B N4 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000390 | Name: | N-(tert-butoxycarbonyl)-L-alanyl-N-{(1R)-5-ammonio-1-[hydroxy(methoxy)boranyl]pentyl}-L-valinamide | Formula: | C19 H40 B N4 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000391 | Name: | 5-S-benzyl-3-({N-[(5-bromo-2-methoxyphenyl)acetyl]-L-valyl}amino)-2,3-dideoxy-5-thio-D-erythro-pentonic acid | Formula: | C26 H33 Br N2 O6 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000392 | Name: | N-(dimethylsulfamoyl)-L-phenylalanyl-N-[(1S,2S)-2-hydroxy-4-{[(2S)-2-methylbutyl]amino}-1-(2-methylpropyl)-4-oxobutyl]-N~6~-(methylcarbamothioyl)-L-lysinamide | Formula: | C32 H57 N7 O6 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000393 | Name: | N-(tert-butoxycarbonyl)-L-alanyl-L-alanyl-L-prolyl-L-glutamic acid | Formula: | C21 H34 N4 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000396 | Name: | N-{(2S)-2-[{N-acetyl-3-cyclohexyl-L-alanyl-N~5~-[amino(iminio)methyl]-L-ornithyl}(methyl)amino]-2-phenylacetyl}-L-methionyl-L-alanyl-L-seryl-3-methyl-L-valinamide | Formula: | C43 H72 N11 O9 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000398 | Name: | N-{(2S)-2-[(N-acetyl-L-threonyl-L-isoleucyl)amino]hexyl}-L-norleucyl-L-glutaminyl-N~5~-[amino(iminio)methyl]-L-ornithinamide | Formula: | C35 H68 N11 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000399 | Name: | N-(3-carboxypropanoyl)-L-valyl-N-{(1R)-1-[(S)-hydroxy(oxido)phosphanyl]-2-phenylethyl}-L-prolinamide | Formula: | C22 H32 N3 O8 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000400 | Name: | SUCCINYL-ALA-PRO-ALA-P-NITROANILIDE | Formula: | C21 H27 N5 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000401 | Name: | PEPTIDOMIMETIC INHIBITOR KI2-PHE-GLU-GLU-NH2 | Formula: | C37 H43 N5 O11 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000402 | Name: | methoxysuccinyl-alanyl-alanyl-prolyl-alanine chloromethyl ketone | Formula: | C20 H33 Cl N4 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000403 | Name: | 4-[(2R)-3-{[(1S,2S,3R,4S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methyl-4-({(1S,2R)-2-methyl-1-[(pyridin-2-ylmethyl)carba
moyl]butyl}carbamoyl)hexyl]amino}-2-{[(naphthalen-1-yloxy)acetyl]amino}-3-oxopropyl]-1H-imidazol-3-ium | Formula: | C45 H62 N7 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000404 | Name: | L-prolyl-L-leucyl-N-hydroxyglycinamide | Formula: | C13 H24 N4 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000405 | Name: | N-acetyl-L-valyl-3,3-dimethyl-L-alpha-aspartyl-N~4~,N~4~-dimethyl-N~1~-[(1R)-3,3,3-trifluoro-1-methyl-2-oxopropyl]-L-aspartamide | Formula: | C23 H36 F3 N5 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000406 | Name: | INHIBITOR ACE-IPA-GLU-GLU-ILE | Formula: | C29 H40 N4 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000407 | Name: | 1-{(2R)-2-[(8R,11S)-8-(2-amino-2-oxoethyl)-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-yl]-2-hydroxyethyl}-L-prolyl-L-isoleucyl-L-valinamide | Formula: | C34 H53 N7 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000409 | Name: | MAZ-PY-(ALPHA ME)PY-N-NH2 | Formula: | C31 H37 N5 O15 P2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000410 | Name: | amino({3-[(3R,5R,14S,16S,21aR)-5,14-dihydroxy-1,4,17-trioxo-16-(2-phenylethyl)icosahydro-1H-pyrrolo[1,2-d][1,4,7,11]tetraazacyclononadecin-3-yl]propyl}amino)methaniminium | Formula: | C30 H50 N7 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000411 | Name: | N-acetyl-L-alanyl-6-ammonio-N-[(1R)-4-carbamimidamido-1-(dihydroxyboranyl)butyl]-L-norleucinamide | Formula: | C16 H35 B N7 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|